The Latest Breaking News from Omicron

MakeMyTrip Ltd (NASDAQ:MMYT) reported third-quarter FY22 sales growth of 102.5% Y/Y and 70.5% Q/Q, to $115.02 million, beating the analyst consensus of $112.35 million. Gross bookings for the quarter increased 93.0% Y/Y and 57.4% Q/Q. Adjusted EPS of $0.12 beat the analyst consensus of $(0.01). Revenue from Air ticketing increased 50.6% Y/Y, Hotels…

Global growth downgraded to 4.4% as body predicts especially marked slowdown for US and China

Covid rules brought in to deal with rising Omicron cases are coming to end this week. Here's what that means for face mask rules in supermarkets across England, from Morrisons to Marks & Spencer

Pfizer Inc and BioNTech SE said on Tuesday they started a clinical trial to test a new version of their vaccine specifically designed to target the COVID-19 Omicron variant, which has eluded some of the protection provided by the original two-dose vaccine regimen. The companies plan to test the immune…

Here's a roundup of top developments in the biotech space over the last 24 hours.

Due to the Omicron Covid variant being so transmissible, it’s important to be aware of the symptoms to avoid spreading it further. Here we take a look at specific signs in your ears, head and eyes

Vaccine booster demand down following message of “less serious” impacts of Omicron

Royal Mail staff absences peaked at 15,000 in early January as Omicron ripped through the UK.

The chief executive of Marston’s expects Brits to flock back to the pub now that Plan B restrictions have been scrapped.